AG-1517 [153436-54-5]
A2501
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameAG-1517 [153436-54-5]
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionEGFR inhibitor.; Tyrphostin AG1517, PD153035, SU5271; PD-153035; Compound 32; Pd 153035
- UNSPSC12352200
References
- Zhang Z, Oyesanya RA, Campbell DJ, et al. Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy. Hepatology. 2010 Sep;52(3):975-86. PMID: 20607690. Powell TJ, Ben-Bassat H, Klein BY, et al. Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors. Br J Dermatol. 1999 Nov;141(5):802-10. PMID: 10583160.